LDHA and neoplasm: In functional assays, RNA interference–mediated knockdown of LDHA or pharmacologic inhibition with the LDHA inhibitor FX11 reduced glycolytic activity, suppressed GBC cell proliferation, invasion and colony formation, promoted apoptosis in vitro, and inhibited tumor growth in vivo.